The FDA’s acting commissioner is taking the highly unusual step of asking for a federal investigation of doctors within her own agency who met with the makers of an Alzheimer’s drug prior to its approval
The Food and Drug Administration’s acting commissioner, Janet Woodcock, is taking the highly unusual step of asking for a federal investigation of doctors within her own agency who met with the makers of an Alzheimer’s drug before the medicine’s recent approval., called for the Office of Inspector General of the Department of Health and Human Services, which oversees the FDA, to review interactions between the drugmaker and FDA staff during the approval process.
During the time when the agency was considering the drug, called Aduhelm, FDA reviewers met with the company, Biogen Inc., that makes the drug. They collaborated with the company to prepare a
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA calls for investigation into its own approval of Biogen’s Alzheimer’s drugThe acting commissioner of the Food and Drug Administration has called for a government investigation into her own agency’s approval of Biogen’s new Alzheimer’s disease drug.
Leer más »
As Delta Surges, FDA Pressured to Fully Approve COVID VaccinesMore and more experts are urging the FDA to grant full approval to the Pfizer and Moderna COVID-19 vaccines because it might jump-start the stalled national vaccination program and slow down the surge of the Delta variant infection.
Leer más »
Appeals court axes FDA ban of electric shock on the disabledThe judges’ 2-1 decision this week will allow the Judge Rotenberg Educational Center in Canton, Mass., to continue using shock devices on its residents.
Leer más »
FDA head calls for investigation into Alzheimer’s drug approvalThe move comes just one day after the agency moved to limit who could receive the controversial drug, made by Biogen.
Leer más »
Acting FDA commissioner calls for independent investigation into approval of Alzheimer's drugUS Food and Drug Administration Acting Commissioner Dr. Janet Woodcock on Friday requested an investigation by the US Department of Health and Human Services Office of Inspector General into the controversial approval of the Alzheimer's disease drug Aduhelm.
Leer más »
FDA Commissioner Calls For Inspector General Probe Into Biogen Alzheimer’s Drug ApprovalThe investigation comes after journalists reported improper back channel communications between Biogen and FDA officials.
Leer más »